MENLO PARK, Calif., Jan. 18, 2017 — Adverum Biotechnologies, Inc. a gene therapy company committed to discovering and developing novel medicines for patients suffering from diseases with few or burdensome treatment options, announced today its participation in the Phacilitate Cell & Gene Therapy World 2017 conference held January 17-20, 2017 in Miami, Florida.